Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | STAT1 | P42224 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL27493073 | 0.92 | KMT2A (0.56) | KMT2AALDH1A1RAB9ACYP1A2SMN1; SMN2 | |
| SCHEMBL1459457 | 0.88 | ALDH1A1 (0.73) | KMT2AALDH1A1RAB9ACYP1A2SMN1; SMN2 | |
| SCHEMBL5682954 | 0.85 | KMT2A (0.67) | KMT2AALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL8856939 | 0.85 | CA12 (0.53) | KMT2AALDH1A1RAB9ACYP1A2NPC1 | |
| SCHEMBL27783040 | 0.85 | CA12 (0.53) | KMT2AALDH1A1RAB9ACYP1A2NPC1 | |
| SCHEMBL27915444 | 0.85 | RAB9A (0.50) | KMT2AALDH1A1RAB9ACYP1A2NPC1 | |
| SCHEMBL8816442 | 0.85 | RAB9A (0.62) | KMT2AALDH1A1RAB9ACYP1A2SMN1; SMN2 | |
| SCHEMBL28680863 | 0.84 | ALDH1A1 (0.77) | KMT2AALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL8319324 | 0.84 | RAB9A (0.64) | KMT2AALDH1A1RAB9ACYP1A2SMN1; SMN2 | |
| SCHEMBL29097191 | 0.84 | KMT2A (0.65) | KMT2AALDH1A1RAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3837008-B1 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | PHARMACYL AB (SE) | 2025-09-24 | — | — | EP | disclosed |
| CN-112703036-B | Substituted benzamides and their use in therapy | 法玛西尔有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-20250064761-A1 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | PHARMACYL AB (SE) | 2025-02-27 | — | — | US | disclosed |
| CN-112770736-B | Novel medical treatment of pathological inflammation | 法玛西尔有限公司 | 2025-01-21 | — | — | CN | disclosed |
| EP-3836912-B1 | COMBINATIONS OF SUBSTITUTED BENZAMIDES AND 5-ASA AGENTS | PHARMACYL AB (SE) | 2024-05-01 | — | — | EP | disclosed |
| US-11896564-B2 | Medical treatment for pathologic inflammation | PHARMACYL AB (SE) | 2024-02-13 | — | — | US | disclosed |
| US-11717500-B2 | Treatment of spondyloarthritis | PHARMACYL AB (SE) | 2023-08-08 | — | — | US | disclosed |
| US-20220087959-A1 | A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATION | PHARMACYL AB (SE) | 2022-03-24 | — | — | US | disclosed |
| US-20210299071-A1 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | PHARMACYL AB (SE) | 2021-09-30 | — | — | US | disclosed |
| US-20210236441-A1 | TREATMENT OF SPONDYLOARTHRITIS | PHARMACYL AB (SE) | 2021-08-05 | — | — | US | disclosed |
| EP-3837008-A2 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | Pharmacyl AB (SE) | 2021-06-23 | — | — | EP | disclosed |
| EP-3836912-A1 | A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATION | Pharmacyl AB (SE) | 2021-06-23 | — | — | EP | disclosed |
| CN-112770736-A | Novel medical treatment of pathological inflammation | 法玛西尔有限公司 | 2021-05-07 | — | — | CN | disclosed |
| CN-112703036-A | Substituted benzamides and their use in therapy | 法玛西尔有限公司 | 2021-04-23 | — | — | CN | disclosed |
| WO-2020035554-A1 | A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATION | PHARMACYL AB (SE) | 2020-02-20 | — | — | WO | disclosed |
| WO-2020035555-A2 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | PHARMACYL AB (SE) | 2020-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896564-B2 | Medical treatment for pathologic inflammation | KIT, IL5, IL6 | KMT2A 3398/4885ALDH1A1 71/4885RAB9A 3779/4885 |
| US-20250064761-A1 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | BRD4, SI, BRD7 | KMT2A 1087/4885ALDH1A1 719/4885RAB9A 2183/4885 |
| US-11717500-B2 | Treatment of spondyloarthritis | SPAST, IL17A, SLC10A2 | KMT2A 4069/4885ALDH1A1 1318/4885RAB9A 3803/4885 |
| US-20210236441-A1 | TREATMENT OF SPONDYLOARTHRITIS | SPAST, IL17A, SLC10A2 | KMT2A 4069/4885ALDH1A1 1318/4885RAB9A 3803/4885 |
| US-20220087959-A1 | A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATION | KIT, IL5, IL1B | KMT2A 3444/4885ALDH1A1 73/4885RAB9A 3724/4885 |
| US-20210299071-A1 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | BRD4, SI, BRD7 | KMT2A 1087/4885ALDH1A1 719/4885RAB9A 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.